Festival of Genomics Boston - October 2017, Boston Convention Center

Stilla Technologies

Stand: D38
  • Other
Stilla Technologies

Stilla Technologies is a Paris-based European Biotechnology company that focuses on accelerating the development of next-generation genetic tests by providing a universal and flexible Digital PCR  solution.

Discover the simplicity of Digital PCR with the Naica System: a unique fast, easy-to-use, versatile and reliable 3-color multiplexing capability!


1 Mail du Professeur Georges Mathé
94 800



Contact Exhibitor

  • Stilla is proud to be part of a Philips-led consortium that has been awarded a Horizon 2020 EU research grant totalling EUR 6.3 million to develop integrated approaches for personalized cancer treatment.

    The four-year research project, ‘Liquid biopsies and IMAging for improved cancer care’ (LIMA), aims to increase the accuracy of both genetic and functional characterization of primary breast cancer and rectal cancer by combining two diagnostic technologies: advanced blood tests called liquid biopsy and Magnetic Resonance Imaging (MRI). The clinical research studies will be carried out at the University Medical Center of Utrecht (UMC Utrecht) in the Netherlands, and the Institut National de la Sante et de la Recherche Medicale in France (INSERM).

1 Results
View all Exhibitors

Book Your Pass

  • Register for your FREE Festival pass   View
  • Poster pass £30 View



Sign up to the mailing list for more information, and to receive the Front Line Genomics magazine

Sign Up